New York: Aspirin -- a common painkiller -- often used to treat pain, fever, and inflammation is likely to reduce the risk for bile duct cancer, finds a new research.
Bile duct cancer -- also called cholangiocarcinoma -- is an aggressive type of cancer that forms in the slender tubes (bile ducts) that carry digestive fluid through the liver.
"The evidence has been accumulating that regular, long-term use of aspirin is associated with a decreased risk of a number of different cancer types, particularly gastrointestinal cancers," said one of the researchers, Lewis Roberts, gastroenterologist and hepatologist at Mayo Clinic in the US.
The findings showed that individuals who took aspirin had a more than a two-and-half to three-and-half times lesser chance of developing bile duct cancer, compared to individuals who did not take aspirin.
The researchers found that aspirin, with it's an anti-inflammatory properties can decrease the risk of bile duct cancer by lessening inflammation through slowing down an enzyme called cyclo-oxygenase (COX), which is known to promote inflammation.
"We know that continuous unremitting inflammation is one of the main factors that promotes cancer of the bile ducts," Roberts added in the paper published in the journal Hepatology.
In addition to the COX enzyme pathway, according to previous studies, aspirin also blocks additional cell-signaling cascades that promote cancer development.
However, it is not yet certain that aspirin is safe to use for cancer prevention.
The team said additional confirmatory studies are needed before aspirin can be recommended for use in preventing bile duct cancer.
Bile duct cancer occurs mostly in people over 50 and can cause symptoms, such as yellowing of the skin and eyes, intense itchiness of the skin, and white stools. It progresses quickly and is difficult to treat.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Bile duct cancer -- also called cholangiocarcinoma -- is an aggressive type of cancer that forms in the slender tubes (bile ducts) that carry digestive fluid through the liver.
"The evidence has been accumulating that regular, long-term use of aspirin is associated with a decreased risk of a number of different cancer types, particularly gastrointestinal cancers," said one of the researchers, Lewis Roberts, gastroenterologist and hepatologist at Mayo Clinic in the US.
The researchers found that aspirin, with it's an anti-inflammatory properties can decrease the risk of bile duct cancer by lessening inflammation through slowing down an enzyme called cyclo-oxygenase (COX), which is known to promote inflammation.
Advertisement
In addition to the COX enzyme pathway, according to previous studies, aspirin also blocks additional cell-signaling cascades that promote cancer development.
Advertisement
The team said additional confirmatory studies are needed before aspirin can be recommended for use in preventing bile duct cancer.
Advertisement
Advertisement
COMMENTS
Advertisement
The Treatment Isn't Always the Cure Scientific Review Finds Aspirin Significantly Cuts Cancer Rates Life On Earth Originates From One Ancestor, Older Than Previously Believed Cops Probing Conspiracy Angle Into Kolkata Hospital Vandalism: 5 Points "Anti-Constitution": Siddaramaiah On Governor's Prosecution Sanction Centre Closely Monitoring Mpox Situation, No New Cases Reported MK Stalin Unveils Mega Industrial Housing For 18,000 Foxconn Women Workers "Effective Immediately": Elon Musk's X Closing Operations In Brazil Track Latest News Live on NDTV.com and get news updates from India and around the world.